Xie J - Search Results

1

Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens.

Marrett E, Kwong WJ, Xie J, Manceur AM, Sendhil SR, Wu E, Ionescu-Ittu R, Subramanian J. Marrett E, et al. Among authors: xie j. Drugs Real World Outcomes. 2023 Dec;10(4):531-544. doi: 10.1007/s40801-023-00383-1. Epub 2023 Sep 2. Drugs Real World Outcomes. 2023. PMID: 37659039 Free PMC article.

2

Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancer.

Li N, Hao Y, Xie J, Lin PL, Zhou Z, Zhong Y, Signorovitch JE, Wu EQ. Li N, et al. Among authors: xie j. Curr Med Res Opin. 2015 Aug;31(8):1573-82. doi: 10.1185/03007995.2015.1062358. Curr Med Res Opin. 2015. PMID: 26074049

3

Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.

Hur P, Lomax KG, Ionescu-Ittu R, Manceur AM, Xie J, Cammarota J, Gautam R, Sanghera N, Kim N, Grom AA. Hur P, et al. Among authors: xie j. Pediatr Rheumatol Online J. 2021 Sep 14;19(1):143. doi: 10.1186/s12969-021-00605-2. Pediatr Rheumatol Online J. 2021. PMID: 34521444 Free PMC article.

4

Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2- Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study.

Li N, Hao Y, Xie J, Lin PL, Koo V, Ohashi E, Wu EQ. Li N, et al. Among authors: xie j. Int J Breast Cancer. 2015;2015:240750. doi: 10.1155/2015/240750. Epub 2015 May 20. Int J Breast Cancer. 2015. PMID: 26078883 Free PMC article.

5

Comparative effectiveness of everolimus-based therapy versus endocrine monotherapy among postmenopausal women with HR+/HER2- metastatic breast cancer: a retrospective chart review in community oncology practices in the US.

Xie J, Hao Y, Li N, Lin PL, Ohashi E, Koo V, Signorovitch JE, Wu EQ, Yardley DA. Xie J, et al. Curr Med Res Opin. 2015 Jun;31(6):1095-103. doi: 10.1185/03007995.2015.1021906. Epub 2015 May 13. Curr Med Res Opin. 2015. PMID: 25971725

6

Real-world effectiveness of everolimus-based therapy versus fulvestrant monotherapy in HR(+)/HER2(-) metastatic breast cancer.

Hao Y, Lin PL, Xie J, Li N, Koo V, Ohashi E, Wu EQ, Rogerio J. Hao Y, et al. Among authors: xie j. J Comp Eff Res. 2015 Aug;4(4):315-26. doi: 10.2217/cer.15.25. J Comp Eff Res. 2015. PMID: 26274793 Free article.

7

Clinical outcomes among HR+/HER2- metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US.

Xie J, Hao Y, Li N, Lin PL, Ohashi E, Koo V, Wu EQ. Xie J, et al. Exp Hematol Oncol. 2015 Dec 12;4:31. doi: 10.1186/s40164-015-0023-0. eCollection 2015. Exp Hematol Oncol. 2015. PMID: 26693096 Free PMC article.

8

A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment.

Ayyagari R, Xie J, Cheng D, Wu EQ, Huang XY, Chen S. Ayyagari R, et al. Among authors: xie j. J Clin Hypertens (Greenwich). 2018 Jun;20(6):1058-1066. doi: 10.1111/jch.13312. J Clin Hypertens (Greenwich). 2018. PMID: 29902367 Free PMC article.

9

Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease in the U.S. Real-World Settings.

Hur P, Yi E, Ionescu-Ittu R, Manceur AM, Lomax KG, Cammarota J, Xie J, Gautam R, Nakasato P, Sanghera N, Kim N, Grom AA. Hur P, et al. Among authors: xie j. Rheumatol Ther. 2022 Feb;9(1):265-283. doi: 10.1007/s40744-021-00402-z. Epub 2021 Dec 7. Rheumatol Ther. 2022. PMID: 34874547 Free PMC article.

10

Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of HR+/HER2- breast cancer with liver metastasis in the USA.

Lin PL, Hao Y, Xie J, Li N, Ohashi E, Koo V, Wu EQ. Lin PL, et al. Among authors: xie j. Expert Opin Pharmacother. 2015;16(14):2101-11. doi: 10.1517/14656566.2015.1074182. Epub 2015 Aug 6. Expert Opin Pharmacother. 2015. PMID: 26290278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17,699 results

Search Page